Trials / Conditions / Methamphetamine Abuse

Methamphetamine Abuse

57 registered clinical trials studyying Methamphetamine Abuse — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Methamphetamine, PrEP, and Intersectional Stigma Study NCT05784467	Arizona State University	N/A
Recruiting	A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Meth NCT06721494	Clear Scientific, Inc.	Phase 2
Not Yet Recruiting	Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD) NCT07309757	Oregon Health and Science University	—
Recruiting	Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder NCT06788587	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Recruiting	Ketamine for Methamphetamine Use Disorder NCT06496750	University of Texas Southwestern Medical Center	Phase 2
Recruiting	Mood and Decision-making in Methamphetamine Use Disorder NCT06410196	Laureate Institute for Brain Research, Inc.	N/A
Recruiting	Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder NCT06233799	National Institute on Drug Abuse (NIDA)	Phase 3
Unknown	ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals NCT05334914	Centre for Addiction and Mental Health	N/A
Completed	A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants NCT06316973	Clear Scientific, Inc.	Phase 1
Completed	tACS Treatment for Cognitive Impairments in Methamphetamine Addicts NCT06292156	Beijing HuiLongGuan Hospital	N/A
Recruiting	Theta Burst TMS for Treatment of Methamphetamine Use Disorder NCT06372288	Carilion Clinic	N/A
Recruiting	Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users NCT05854667	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Active Not Recruiting	Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM) NCT05700994	Oregon Health and Science University	N/A
Unknown	Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder NCT05593796	Assiut University	N/A
Unknown	Skin Disease in Methamphetamine Abuse NCT05971043	Assiut University	—
Active Not Recruiting	Contingency Management for Drug Use: Does Age Matter? NCT05521854	Wake Forest University Health Sciences	N/A
Terminated	Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 NCT05034874	InterveXion Therapeutics, LLC	Phase 2
Completed	Demonstration of a Digital Care Program for Methamphetamine Use Disorder NCT05206175	Affect Therapeutics, Inc.	N/A
Completed	rTMS for Stimulant Use Disorders NCT04907357	Medical University of South Carolina	N/A
Recruiting	Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives NCT04927143	Wake Forest University Health Sciences	N/A
Completed	Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics NCT04706624	Hanoi Medical University	N/A
Completed	FASTLANE II: Reducing Sex, Drug, and Mental Health Risk NCT04109014	University of Southern California	N/A
Completed	Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Us NCT05266716	Affect Therapeutics, Inc.	N/A
Completed	Delivering Contingency Management in Outpatient Addiction Treatment NCT04544124	University of Calgary	N/A
Completed	Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder NCT05550493	Adai Technology (Beijing) Co., Ltd.	N/A
Completed	Cardiovascular Effects of Prenatal Methamphetamine Exposure NCT04616625	University of California, Davis	—
Withdrawn	A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders NCT04883021	University of New Mexico	N/A
Completed	Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse NCT04264741	Shanghai Mental Health Center	N/A
Suspended	Screening of Pulmonary Hypertension in Methamphetamine Abusers NCT04019600	The University of Hong Kong	—
Completed	Change in Cognitive Function in Stimulant Users NCT04061941	The University of Hong Kong	—
Completed	Exercise in Methamphetamine Use Disorder Upregulation and Neural Function NCT03709667	University of California, Los Angeles	EARLY_Phase 1
Completed	Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use NCT03864653	Friends Research Institute, Inc.	N/A
Completed	The Getting Off App for Methamphetamine-Using Gay and Bisexual Men NCT03884946	Friends Research Institute, Inc.	N/A
Completed	Amphetamine Induced Adult Respiratory Distress Syndrome NCT05611385	Arrowhead Regional Medical Center	—
Completed	Stimulant Use and Methylation in HIV NCT05916989	Florida International University	—
Completed	Study of Antibody for Methamphetamine Outpatient Therapy NCT03336866	InterveXion Therapeutics, LLC	Phase 1 / Phase 2
Recruiting	rTMS for Craving in Methamphetamine Use Disorder NCT03470480	Oregon Health and Science University	N/A
Terminated	Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users NCT03059563	University of California, Los Angeles	Phase 1
Completed	Pharmacogenetics of Naltrexone for Stimulant Abuse NCT03226223	New York State Psychiatric Institute	Phase 2
Completed	Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa NCT02907853	University of California, Los Angeles	N/A
Completed	Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM NCT02008526	Friends Research Institute, Inc.	N/A
Completed	Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse NCT01967381	University of Kentucky	EARLY_Phase 1
Completed	Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade NCT01822132	Oregon Health and Science University	N/A
Completed	Buspirone as a Candidate Medication for Methamphetamine Abuse NCT01843205	University of Kentucky	Phase 1
Completed	Safety Study of Ch-mAb7F9 for Methamphetamine Abuse NCT01603147	InterveXion Therapeutics, LLC	Phase 1
Completed	Varenicline for Methamphetamine Dependence NCT01365819	University of California, Los Angeles	Phase 2
Unknown	Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Depe NCT01273701	National Taiwan University Hospital	N/A
Completed	Varenicline as a Treatment for Methamphetamine Dependence NCT01571167	Baylor College of Medicine	Phase 1
Completed	NAC as a Potential Treatment for Methamphetamine Dependence NCT01063205	Baylor College of Medicine	Phase 1
Withdrawn	RTI-336 as a Treatment for Methamphetamine Dependence NCT01601717	Baylor College of Medicine	Phase 1
Completed	Varenicline vs Placebo for the Treatment of Methamphetamine Dependence NCT01011829	University of California, Los Angeles	Phase 2
Terminated	Safety Assessment of Atomoxetine With MA IV Administration NCT01019707	University of California, Los Angeles	Phase 1
Completed	Rivastigmine as a Treatment for Methamphetamine Dependence NCT01073319	Baylor College of Medicine	Phase 1
Completed	An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methampheta NCT01062451	Baylor College of Medicine	Phase 1
Completed	Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OR NCT00603434	University of Cincinnati	Phase 1
Withdrawn	Varenicline-Methamphetamine Interaction Study (2008) NCT00733967	Baylor College of Medicine	Phase 1
Completed	Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine NCT00291512	University of California, San Diego	Phase 2